Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 530
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
for
Liver
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05879159
Recruiting
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05039632
Phase1, Phase2, Recruiting
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
for
Metastatic Malignancy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05394337
Phase1, Phase2, Recruiting
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
for
Solid Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06576037
Phase1, Recruiting
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
for
Recurrent Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04140487
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05042687
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
for
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma,
Location: Jacksonville FL, Nassau Bay TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00477100
Recruiting
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
for
Breast Ductal Carcinoma In Situ, COVID-19 Infection,
Location: League City TX, Houston TX, Conroe TX, Sugar Land TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT04169542
Recruiting
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
for
Dyspnea
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06336642
Phase2, Recruiting
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
for
Endometrial Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT06409052
Recruiting
Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
for
Relapsed/Refractory Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT06066359
Phase1, Phase2, Recruiting
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
for
Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05694559
Recruiting
The Rise in Robotic Atypical Segmentectomies
for
Lung Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT04644952
Recruiting
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
for
Advanced Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06369259
Phase2, Recruiting
A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
for
Metastatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06693687
Recruiting
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
for
Endometrial Clear Cell Adenocarcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05049538
Recruiting
CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
for
Acute Myeloid Leukemia With Gene Mutations,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04493164
Phase2, Recruiting
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
for
Estrogen Receptor Negative, HER2 Positive Breast Carcinoma,
Location: Voorhees Township NJ, Pittsburgh PA, Charlotte NC,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 30+
Code: NCT02945579
Recruiting
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
for
Malignant Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06629584
Phase2, Recruiting
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer